DK0656203T3 - Injicerbart mikroskum indeholdende et scleroserende middel - Google Patents

Injicerbart mikroskum indeholdende et scleroserende middel

Info

Publication number
DK0656203T3
DK0656203T3 DK94918886T DK94918886T DK0656203T3 DK 0656203 T3 DK0656203 T3 DK 0656203T3 DK 94918886 T DK94918886 T DK 94918886T DK 94918886 T DK94918886 T DK 94918886T DK 0656203 T3 DK0656203 T3 DK 0656203T3
Authority
DK
Denmark
Prior art keywords
microfoam
sclerosing
sclerosing agent
foam containing
micro foam
Prior art date
Application number
DK94918886T
Other languages
Danish (da)
English (en)
Inventor
Garrido Juan Cabrera
Garcia-Olmedo Juan Cabrera
Original Assignee
Btg Int Ltd
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8282315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0656203(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Btg Int Ltd, British Tech Group filed Critical Btg Int Ltd
Application granted granted Critical
Publication of DK0656203T3 publication Critical patent/DK0656203T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/07—Microporous membranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK94918886T 1993-06-23 1994-06-21 Injicerbart mikroskum indeholdende et scleroserende middel DK0656203T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES09301413A ES2068151B1 (es) 1993-06-23 1993-06-23 Microespuma inyectable para esclerosis.
PCT/ES1994/000064 WO1995000120A1 (es) 1993-06-23 1994-06-21 Microespuma inyectable conteniendo un agente esclerosante

Publications (1)

Publication Number Publication Date
DK0656203T3 true DK0656203T3 (da) 1999-11-01

Family

ID=8282315

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94918886T DK0656203T3 (da) 1993-06-23 1994-06-21 Injicerbart mikroskum indeholdende et scleroserende middel

Country Status (9)

Country Link
US (3) US5676962A (es)
EP (1) EP0656203B3 (es)
AT (1) ATE179598T1 (es)
AU (1) AU7001294A (es)
DE (1) DE69418286T2 (es)
DK (1) DK0656203T3 (es)
ES (2) ES2068151B1 (es)
GR (1) GR3030248T3 (es)
WO (1) WO1995000120A1 (es)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2068151B1 (es) 1993-06-23 1995-11-16 Cabrera Garrido Juan Microespuma inyectable para esclerosis.
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
GB9912356D0 (en) 1999-05-26 1999-07-28 Btg Int Ltd Generation of microfoam
AU2005205772B2 (en) * 1999-05-26 2009-04-30 Btg International Limited Generation of Therapeutic Microfoam
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
WO2001085136A2 (en) 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7077836B2 (en) * 2000-07-21 2006-07-18 Vein Rx, Inc. Methods and apparatus for sclerosing the wall of a varicose vein
US20030120256A1 (en) * 2001-07-03 2003-06-26 Syntheon, Llc Methods and apparatus for sclerosing the wall of a varicose vein
GB0028692D0 (en) 2000-11-24 2001-01-10 Btg Int Ltd Generation of therapeutic microform
GB2369996B (en) * 2000-12-18 2004-06-23 S T D Pharmaceutical Products Method and apparatus for producing an injectable foam
US8512680B2 (en) 2001-08-08 2013-08-20 Btg International Ltd. Injectables in foam, new pharmaceutical applications
WO2003013475A1 (es) * 2001-08-08 2003-02-20 Garcia-Olmedo Dominguez Maria Inyectables en espuma. nuevas aplicaciones farmaceuticas
EP1458360B1 (en) 2001-12-19 2011-05-11 Novartis AG Pulmonary delivery of aminoglycosides
WO2003084173A1 (en) * 2002-03-28 2003-10-09 British Telecommunications Public Limited Company Synchronisation in multi-modal interfaces
GB0212047D0 (en) 2002-05-24 2002-07-03 Btg Int Ltd Generation of therapeutic microfoam
GB0300586D0 (en) * 2003-01-10 2003-02-12 Btg Int Ltd Therapeutic microfoam
ES2216708B1 (es) * 2003-04-08 2006-02-16 Antonio Luis Cabrera Garrido "solucion esclerosante".
US7314466B2 (en) * 2003-10-02 2008-01-01 Lary G Banning Minimally invasive vascular surgery
US8048439B2 (en) 2003-11-17 2011-11-01 Btg International Ltd. Therapeutic foam
US20060062736A1 (en) * 2003-11-17 2006-03-23 Wright David D I Therapeutic foam
ES2247898B1 (es) * 2003-12-18 2006-12-01 Universidad Complutense De Madrid Utilizacion de una inyeccion previa de polidocamol en forma de microespuma para la extirpacion indolora de varices mediante laser.
ITMI20041056A1 (it) * 2004-05-26 2004-08-26 Garrido Antonio Luis Cabrera Uso in campo medico diagnostico e flebo logico di una kiscela di gas sterili e fisiologicamente accettabili
US20080200871A1 (en) * 2005-01-14 2008-08-21 Slater Charles R Valve System For a Medical Device Having an Inflatable Member
GB0509824D0 (en) 2005-05-13 2005-06-22 Btg Int Ltd Therapeutic foam
EP2010249A2 (en) * 2006-04-04 2009-01-07 Vnus Medical Technologies, Inc. Method and apparatus for generating vascular treatment foam
US9307995B2 (en) 2006-06-15 2016-04-12 Cook Medical Technologies Llc Methods, systems and devices for the delivery of endoluminal prostheses
US20080050436A1 (en) * 2006-08-25 2008-02-28 Chu Jack F Methods and compounds for obliteration of vessels
US20190070397A1 (en) * 2006-11-27 2019-03-07 Frank Levy Apparatus and method for producing co2 enriched medical foam
KR101547610B1 (ko) 2006-12-21 2015-08-26 비티지 인터내셔널 리미티드 치료학적 포말을 생성시키는 장치 및 방법
US8029560B2 (en) * 2007-09-12 2011-10-04 Cook Medical Technologies Llc Enhanced remodelable materials for occluding bodily vessels
US8157747B2 (en) 2008-02-15 2012-04-17 Lary Research & Development, Llc Single-use indicator for a surgical instrument and a surgical instrument incorporating same
US10143455B2 (en) 2011-07-20 2018-12-04 Covidien LLP Enhanced ultrasound visualization of intravascular devices
CN102481153B (zh) * 2009-02-20 2015-11-25 柯惠有限合伙公司 用于治疗静脉机能不全的静脉闭塞的方法和装置
WO2012170538A2 (en) 2011-06-06 2012-12-13 Cook Medical Technologies Llc Vascular occlusion devices and methods
US8808620B1 (en) 2012-02-22 2014-08-19 Sapheon, Inc. Sterilization process design for a medical adhesive
JP2012246306A (ja) * 2012-08-22 2012-12-13 Btg Internatl Ltd 注射可能な泡製剤および新規な医薬的適用
US20160346423A1 (en) 2014-01-07 2016-12-01 Covidien Lp Cyanoacrylate compositions including non-agglomerating radiopaque nanoparticles
CA2950483C (en) 2014-06-03 2022-06-28 Antoni PUIG DOMENECH Methods, devices, systems and kits for preparing compositions for care and repair of varicose veins
EP2962681A1 (en) 2014-07-03 2016-01-06 Swiss VX Venentherapie und Forschung GmbH Devices and methods for injectable vascular sclerofoams using a carrier made of human blood and uses thereof
US20160045416A1 (en) * 2014-08-14 2016-02-18 John Daniel Dobak Ethanolamine oleate formulations for treatment of adipose tissue
US9687455B2 (en) 2014-08-14 2017-06-27 John Daniel Dobak Sodium tetradecyl sulfate formulations for treatment of adipose tissue
US9351945B1 (en) 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
GB201611778D0 (en) 2016-07-06 2016-08-17 Provensis Ltd Method and device for producing foam
GB201612925D0 (en) * 2016-07-26 2016-09-07 Provensis Ltd Method and device for generating injectable foam
US11109867B2 (en) 2018-03-16 2021-09-07 Boston Scientific Scimed, Inc. Devices and methods for vein closure
IT201800006109A1 (it) 2018-06-07 2019-12-07 Polidocanolo per uso come immunomodulatore
US20240149020A1 (en) 2022-11-04 2024-05-09 Controlled Delivery Systems, Inc. Catheters for the aspiration controlled delivery of closure agents

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1547768A (fr) 1967-10-09 1968-11-29 Récipient remplissable à dispositif décompresseur
FR2105332A5 (es) 1970-09-01 1972-04-28 Oreal
US3955720A (en) 1972-11-15 1976-05-11 Malone David C Low pressure dispensing apparatus with air pump
US3970219A (en) 1975-03-03 1976-07-20 Spitzer Joseph G Aerosol containers for foaming and delivering aerosols and process
US4019657A (en) 1975-03-03 1977-04-26 Spitzer Joseph G Aerosol containers for foaming and delivering aerosols
US4040420A (en) 1976-04-22 1977-08-09 General Dynamics Packaging and dispensing kit
US4127131A (en) 1977-06-20 1978-11-28 Johnson & Johnson Hub assembly for use in the filtration of fluids and method of making the same
US4276885A (en) 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4292972A (en) 1980-07-09 1981-10-06 E. R. Squibb & Sons, Inc. Lyophilized hydrocolloio foam
DE3048744A1 (de) 1980-12-23 1982-07-22 Metzeler Kautschuk GmbH, 8000 München Anordnung zum abdichten einer mehrscheibenverglasung
DE3050812C2 (de) 1980-12-23 1985-03-21 B. Braun Melsungen Ag, 3508 Melsungen Katheterisierungsvorrichtung
DE3048774C2 (de) 1980-12-23 1984-03-08 B. Braun Melsungen Ag, 3508 Melsungen Katheterisierungsvorrichtung
DE3141641A1 (de) * 1981-10-16 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Ultraschall-kontrastmittel und dessen herstellung
US4718433A (en) 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
DE3313947A1 (de) 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel
US5141738A (en) 1983-04-15 1992-08-25 Schering Aktiengesellschaft Ultrasonic contrast medium comprising gas bubbles and solid lipophilic surfactant-containing microparticles and use thereof
DE3324754A1 (de) 1983-07-06 1985-01-17 Schering AG, 1000 Berlin und 4709 Bergkamen Ultraschallkontrastmittel sowie dessen herstellung
DE3417182A1 (de) 1984-05-09 1985-11-14 Gerald Dr. 8000 München Hauer Spritzen-set
GB8522813D0 (en) 1985-09-16 1985-10-23 Unilever Plc Package
DE8704600U1 (es) 1987-03-27 1987-10-15 Cocon Kunststoffen B.V., Arkel, Nl
IE61591B1 (en) * 1987-12-29 1994-11-16 Molecular Biosystems Inc Concentrated stabilized microbubble-type ultrasonic imaging agent and method of production
CH676456A5 (es) 1988-04-05 1991-01-31 Supermatic Kunststoff Ag
US4957656A (en) 1988-09-14 1990-09-18 Molecular Biosystems, Inc. Continuous sonication method for preparing protein encapsulated microbubbles
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5084011A (en) 1990-01-25 1992-01-28 Grady Daniel J Method for oxygen therapy using hyperbarically oxygenated liquid
US5064103A (en) 1990-05-23 1991-11-12 Rjs Industries, Inc. Foam dispenser having a plurality of sieves
WO1992005806A1 (en) * 1990-10-05 1992-04-16 Sintetica S.A. Method for the preparation of stable suspensions of hollow gas-filled microspheres suitable for ultrasonic echography
FR2672038B1 (fr) 1991-01-25 1993-05-14 Oreal Dispositif distributeur de mousse a partir d'un recipient pressurise.
DE4301820C2 (de) 1993-01-23 1996-04-25 Henkel Kgaa Schäumende Emulsionen, Verfahren zu ihrer Herstellung und ihre Verwendung
NL9300517A (nl) 1993-03-23 1994-10-17 Airspray Int Bv Schuimvormingssamenstel, een daarvoor geschikte spuitkop en een spuitbus die een dergelijk samenstel omvat.
ES2068151B1 (es) 1993-06-23 1995-11-16 Cabrera Garrido Juan Microespuma inyectable para esclerosis.
US5623085A (en) 1994-09-23 1997-04-22 Rohm And Haas Company Method for reducing microfoam in a spray-applied waterborne composition
AU3896395A (en) 1994-10-11 1996-05-02 James A. Monson Dispensing apparatus for foaming compositions and method
GB9503119D0 (en) 1995-02-17 1995-04-05 Durand Ltd Medication and apparatus and method of applying medication
GB9823029D0 (en) 1998-10-22 1998-12-16 Giltech Ltd Packaging system
FR2775436A1 (fr) 1998-02-27 1999-09-03 Alain Monfreux Dispositif pour l'administration parenterale d'une composition sous forme d'une mousse
FR2775433A1 (fr) 1998-02-27 1999-09-03 Alain Monfreux Dispositif pour la production de mousse dans un corps de seringue
DE29819174U1 (de) 1998-10-28 1999-01-28 Vogelsang K Gmbh Schutzkappe für eine Zweikomponenten-Lack-Sprühdose
ES1043183Y (es) 1999-05-03 2000-04-01 Mingo Fco Javier Garcia Dispositivo para producir esclerosante espumado.
GB9912356D0 (en) 1999-05-26 1999-07-28 Btg Int Ltd Generation of microfoam
US6561237B1 (en) 2000-11-28 2003-05-13 Brasscorp Ltd. Apparatus and method for urging fluid into a pressurized system

Also Published As

Publication number Publication date
EP0656203B1 (en) 1999-05-06
ES2131689T3 (es) 1999-08-01
ES2068151B1 (es) 1995-11-16
DE69418286T2 (de) 1999-10-14
ATE179598T1 (de) 1999-05-15
ES2131689T7 (es) 2012-03-16
USRE40640E1 (en) 2009-02-17
WO1995000120A1 (es) 1995-01-05
ES2068151A1 (es) 1995-04-01
US5676962A (en) 1997-10-14
EP0656203A1 (en) 1995-06-07
AU7001294A (en) 1995-01-17
EP0656203B3 (en) 2011-01-26
GR3030248T3 (en) 1999-08-31
USRE38919E1 (en) 2005-12-13
DE69418286D1 (de) 1999-06-10

Similar Documents

Publication Publication Date Title
DK0656203T3 (da) Injicerbart mikroskum indeholdende et scleroserende middel
Sicuteri et al. Serotonin—bradykinin potentiation on the pain receptors in man
CA2546232A1 (en) Therapeutic foam
KR910016317A (ko) 이온전기도입에 의한 딜리버리를 증가시키는 방법 및 여기에 사용되는 조성물
DE69330728D1 (de) Wasserfreie schäumende Zusammensetzung mit geringer Konzentration von Tensiden und hohem Gehalt an Glycerin und Weichmachern, wie Ölen und Estern
DE3856096D1 (de) Verfahren zur Behandlung der mit dem Rauchstop verbundenen Entwöhnungssymptome sowie Mittel zur Verwendung in diesem Verfahren
ATE96285T1 (de) Verfahren zur entfernung von cholesterin bzw. cholesterinestern aus eigelb.
ATE167400T1 (de) Lys-plasminogen in der verhütung und behandlung von ischämie und reperfusionschäden
AT353397B (de) Injektionsspritze zum einspritzen von fluessigkeiten in blutgefaesse lebender koerper
ATE163654T1 (de) Überkritische flüssigkeitsextraktion mit hydrofluoralkanen
AR218071A1 (es) Procedimiento para mejorar el aroma y la espumosidad de vinos espumantes de diversos tipos,inclusive el champana y el vino asi tratados
DK0845215T3 (da) Indretning til injection af væske i et levnedsmiddel
DE59209926D1 (de) Verfahren zur herstellung von wirkstoffkomplexen
US20050074399A1 (en) Minimally invasive vascular surgery
FR2300574A2 (fr) Composition a base d'huile vegetale metabolisab
DE69106078T2 (de) Verfahren zur Zartmachung von Fleisch vor dem Schlachten.
Obermaier et al. Exogenous and endogenous nitric oxide donors improve post-ischemic tissue oxygenation in early pancreatic ischemia/reperfusion injury in the rat
GERSHUNI et al. Decompression of an experimental compartment syndrome in dogs with hyaluronidase
Sadeghi et al. Safety of plasmin in the setting of concomitant aspirin and heparin administration in an animal model of bleeding
Diffang et al. The effect of alpha-blocking agents on the amount of intravascular fibrin in the lungs during induced intravascular coagulation in rats
RU98113113A (ru) Способ склерозирования вен при варикозе
Bernbach Compression Sclerotherapy
DK0733371T3 (da) Middel til subkutan administrering af protein C
RU2000126214A (ru) Способ инъекционного лечения варикозного расширения вен нижних конечностей
Strejcek et al. The Effect of Sclerotherapy on the Number of Circulating Endothelial Cells (CEC)